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This was a cross-sectional, hospital based, case study 
conducted at Khartoum Children’s Emergency Hospital (KCEH) 
during the period from July 2004 to February 2005. The aim of the 
study was to assess iron status in patients who had anaemia not 
attributed to haemolysis between the age 6 months and 16 years.   
Hundred anaemic patients were included in the study. Thirty 
one children (31%) had history of pica, (04%) had history of 
bilharziasis as well as worms infestation and none had history of 
dysphagia. On examination (93%) were pale, (50%) had smooth 
tongue, (24%) had splenomegaly and (26%) had signs of other 
vitamins deficiency.  
Haematological assessment showed (98%) had low Hb 
level, (44%) had low (MCV), (24%) with low (PCV), (27%) low 
(MCH) and (26%) with low (MCHC). There was no difference 
between gender and haemoglobin level. Iron study results showed 
that (66%) with low serum iron and (33%) with normal iron level. 
Only (21%) had low ferritin and (50%) with normal ferritin. All the 
results of (TIBC) were either normal or high. Serum iron results 
were related to (MCH), (MCV), history of worms, bilharziasis and 







   
  
iron level is related to cow's and goat's milk as supplements. 
Ferritin results showed the majority of ferritin levels were either 
normal (50%) or elevated (29%). This may be attributed to its 
elevation during inflammation even in patients with low iron stores.  
The study concluded that iron deficiency is the commonest 
cause of anaemia in the studied group particularly the lower social 
class. Iron evaluation should not depend on a single test like ferritin 
level. The study recommended that further studies for evaluation of 
other causes of anaemia beside the etiological causes of iron 
deficiency are needed. Routine investigations of iron for anaemic 
















   
  
  ﻤﻠﺨﺹ ﺍﻷﻁﺭﻭﺤﺔ
 ﺴﺒﺘﻤﺒﺭ ﺒﻴﻥ ﻤﺎ ﺍﻟﻔﺘﺭﺓ ﻓﻰ ﺍﻟﺨﺭﻁﻭﻡ ﺍﻷﻁﻔﺎل ﺤﻭﺍﺩﺙ ﻤﺴﺘﺸﻔﻰ ﻓﻰ ﺍﺠﺭﻴﺕ ﺍﻟﺩﺭﺍﺴﺔ ﻫﺫﻩ
 ﻋﻨﺼﺭ ﻤﺴﺘﻭﻯ ﺤﺎﻟﺔ ﻋﻠﻰ ﺍﻟﻭﻗﻭﻑ ﻫﻭ ﺍﻟﺩﺭﺍﺴﺔ ﻤﻥ ﺍﻟﻬﺩﻑ ﻜﺎﻥ. ﻡ5002 ﻓﺒﺭﺍﻴﺭ ﻭﺤﺘﻰ ﻡ4002
 ﺍﻻﻨﺤﻼﻟﻰ ﺍﻟﺩﻡ ﻓﻘﺭ ﻷﻤﺭﺍﺽ ﻤﻌﺯﻯ ﻏﻴﺭ ﺍﻟﺩﻡ ﻓﻰ ﻓﻘﺭ ﻟﺩﻴﻬﻡ ﺍﻟﺫﻴﻥ ﺍﻷﻁﻔﺎل ﻓﻰ ﺍﻟﺩﻡ ﻓﻰ ﺍﻟﺤﺩﻴﺩ
  . ﺴﻨﺔ 61 ﻭﺤﺘﻰ ﺃﺸﻬﺭ 6 ﻋﻤﺭ ﻤﻥ ﻔﺎلﺍﻷﻁ ﻓﻰ
 ﻟﺩﻴﻬﻡ ﻤﻨﻬﻡ ﺒﺎﻟﻤﺎﺌﺔ ﺜﻼﺜﻭﻥ. ﺒﺎﻟﻤﺴﺘﺸﻔﻰ ﺤﺠﺯﻫﻡ ﺘﻡ ﻤﺭﻴﺽ 001 ﺍﻟﺩﺭﺍﺴﺔ ﺸﻤﻠﺕ ﻭﻗﺩ
ﻟﺩﻴﻬﻡ ﺘﺎﺭﻴﺦ ﺇﺼﺎﺒﺔ ﺒﺩﺍﺀ ﺍﻟﻤﻨﺸﻘﺎﺕ ﻭﻋﺩﺩ ﻤﻤﺎﺜل ﺒﺩﻴﺩﺍﻥ %( 40)، ﺍﻟﻁﻴﻥ ﺒﺄﻜل ﺴﺎﺒﻕ ﺘﺎﺭﻴﺦ
 ﺩﻴﻬﻡﻟ%( 39 )ﺃﻥ ﻭﺠﺩ ﺍﻟﺴﺭﻴﺭﻱ ﺍﻟﻜﺸﻑ ﺒﻌﺩ. ﻻ ﻴﻭﺠﺩ ﺃﺤﺩ ﻟﺩﻴﻪ ﺃﻋﺭﺍﺽ ﻋﺴﺭ ﺍﻟﺒﻠﻊ. ﻤﻌﻭﻴﺔ
%( 62)ﻭ ﺍﻟﻁﺤﺎل ﻓﻰ ﺘﻀﺨﻡ ﻟﺩﻴﻬﻡ%( 42 )ﺍﻟﻠﺴﺎﻥ، ﻤﻠﻭﺴﺔ ﻟﺩﻴﻬﻤﻡ%( 05 )ﺍﻟﺠﺴﻡ، ﻓﻰ ﺸﺤﻭﺏ
  . ﺍﻟﻔﻴﺘﺎﻤﻴﻨﺎﺕ ﻋﻭﺯ ﺃﻋﺭﺍﺽ ﻟﺩﻴﻬﻡ
    ﺍﻟﻁﺒﻴﻌﻲ ﻤﻥ ﺃﻗل ﻟﺩﻴﻬﻡ ﺍﻟﺩﻡ ﺨﻀﺎﺏ ﻤﻨﻬﻡ (%89 )ﺃﻥ ﺍﻟﺩﻡ ﺘﺤﻠﻴل ﻨﺘﺎﺝ ﺃﻭﻀﺤﺕ
       : ﻲﻴﻠ ﻜﻤﺎ ﺍﻟﻁﺒﻴﻌﻲ ﻤﻥ ﺃﻗل ﻜﺎﻨﺕ ﺍﻟﺘﻰ ﺍﻟﺤﻤﺭﺍﺀ ﺍﻟﺩﻡ ﻜﺭﻴﺎﺕ ﺩﺍﻻﺕ ﻨﺴﺏ ﻭﻜﺎﻨﺕ( ﺩﻡ ﻓﻘﺭ)
 ﺩﻡ ﺨﻀﺎﺏ  ﻤﺘﻭﺴﻁ%( 72 )ﺍﻟﻤﺘﺭﺍﻜﻡ،  ﺍﻟﺨﻠﻴﺔ ﺤﺠﻡ%( 42 )ﺍﻟﺨﻠﻴﺔ، ﺤﺠﻡ ﻤﺘﻭﺴﻁ%( 44)
 ﻤﺴﺘﻭﻯ ﻓﻰ ﺍﻟﺠﻨﺴﻴﻥ ﺒﻴﻥ ﻓﺭﻕ ﻴﻭﺠﺩ ﻻ. ﺍﻟﺨﻠﻴﺔ ﺩﻡ ﺨﻀﺎﺏ ﺘﺭﻜﻴﺯ ﻤﺘﻭﺴﻁ%( 62) ﻭ ﺍﻟﺨﻠﻴﺔ
 ﻋﻨﺼﺭ ﻤﺴﺘﻭﻯ ﻟﺩﻴﻬﻡ ﻤﻨﻬﻡ%( 66 )ﺃﻥ ﻭﻀﺢ ﺍﻟﺩﻡ ﻓﻰ ﺍﻟﺤﺩﻴﺩ ﺘﺤﻠﻴل ﻨﺘﺎﺌﺞ ﺃﻤﺎ. ﺍﻟﺩﻡ ﺨﻀﺎﺏ
 ﺍﻟﻔﻴﺭﺘﻴﻥ ﺤﺎﻟﺔ ﺃﻤﺎ. ﻁﺒﻴﻌﻲ ﺍﻟﺤﺩﻴﺩ ﻋﻨﺼﺭ ﻤﺴﺘﻭﻯ ﻤﻨﻬﻡ%( 33 )ﺒﻴﻨﻤﺎ ﻲﺍﻟﻁﺒﻴﻌ ﻤﻥ ﺃﻗل ﺍﻟﺤﺩﻴﺩ
 ﺍﺭﺘﺒﺎﻁ ﺴﻌﺔ  ﺤﺎﻻﺕ ﻜل ﻟﻜﻥ. ﻁﺒﻴﻌﻲ ﻤﻨﻪ%( 05) ﻭ ﺍﻟﻁﺒﻴﻌﻲ ﻤﻥ ﺃﻗل ﻤﺴﺘﻭﺍﻩ ﻤﻨﻪ%( 12 )ﻓﺈﻥ
 ﺩﻡ ﺨﻀﺎﺏ ﻤﺘﻭﺴﻁ ﻤﻊ ﻋﻼﻗﺔ ﻟﻬﺎ ﺍﻟﺤﺩﻴﺩ ﻋﻨﺼﺭ ﻨﺘﺎﺌﺞ. ﻤﺭﺘﻔﻌﺔ ﺃﻭ ﻁﺒﻴﻌﻴﺔ ﺇﻤﺎ ﺍﻟﻜﻠﻴﺔ ﺍﻟﺤﺩﻴﺩ







   
  
 ﺍﻟﺤﺩﻴﺩ ﻋﻨﺼﺭ ﻤﺴﺘﻭﻯ ﻜﺫﻟﻙ. ﺍﻟﻠﺴﺎﻥ ﻭﻤﻠﻭﺴﺔ ﺍﻟﻁﺤﺎل ﺘﻀﺨﻡ ﻤﻊ ﻋﻼﻗﺔ ﻟﻬﺎ ﻟﻴﺴﺕ ﻟﻜﻨﻬﺎ ﺍﻟﻁﻴﻥ
 ﻓﻤﻌﻅﻡ ﺍﻟﻔﻴﺭﺘﻴﻥ ﻋﻨﺼﺭ ﺃﻤﺎ.ﺍﻷﻡ ﻟﻠﺒﻥ ﺘﻜﻤﻴﻠﻲ ﻜﻁﻌﺎﻡ ﻤﺎﻋﺯﻭﺍﻟ ﺍﻟﺒﻘﺭ ﻟﺒﻥ ﺘﻨﺎﻭل ﻤﻊ ﻋﻼﻗﺔ ﻟﻪ
 ﺤﺎﻻﺕ ﻭﺠﻭﺩ ﺤﺎﻟﺔ ﻓﻰ ﺃﻨﻪ ﺇﻟﻰ ﻴﻌﺯﻯ ﻙﻭﺫﻟ%( 92) ﻤﺭﺘﻔﻌﺔ ﺃﻭ%( 05 )ﻁﺒﻴﻌﻴﺔ ﺃﻤﺎ ﻨﺘﺎﺌﺠﻪ
  . ﺍﻟﺤﺩﻴﺩ ﻟﻌﻨﺼﺭ ﻤﻨﺨﻔﺽ ﻤﺴﺘﻭﻯ ﻭﺠﻭﺩ ﻋﻨﺩ ﺤﺘﻰ ﻴﺭﺘﻔﻊ ﻤﺴﺘﻭﺍﻩ ﻓﺈﻥ ﺒﺎﻟﺠﺴﻡ ﺍﻟﺘﻬﺎﺒﻴﺔ
 ﻤﺠﻤﻭﻋﺔ ﻓﻰ ﺸﻴﻭﻋﺎﹰ ﺍﻟﺩﻡ ﻓﻘﺭ ﺃﺴﺒﺎﺏ ﺃﻜﺜﺭ ﻫﻭ ﺍﻟﺤﺩﻴﺩ ﻋﻭﺯ ﺃﻥ ﺕ ﺍﻟﺩﺭﺍﺴﺔﺴﺘﺨﻠﺼﺍ
 ﻴﺠﺏ ﺴﻡﺍﻟﺠ ﻓﻰ ﺍﻟﺤﺩﻴﺩ ﺤﺎﻟﺔ ﺘﻘﻴﻴﻡ ﺃﻥ ﻜﻤﺎ ، ﺍﻟﺩﻨﻴﺎ ﺍﻻﺠﺘﻤﺎﻋﻴﺔ ﺍﻟﻁﺒﻘﺎﺕ ﺃﻁﻔﺎلﻭﺒﺎﻷﺨﺹ  ﺍﻟﺒﺤﺙ
 ﺃﺴﺒﺎﺏ ﺒﺒﺤﺙ ﺍﻟﻘﺎﺩﻤﺔ ﺍﻟﺩﺭﺍﺴﺎﺕ ﻓﻰ ﻨﻭﺼﻰ ﻟﺫﺍ. ﺍﻟﻔﻴﺭﺘﻴﻥ ﻤﺜل ﻭﺍﺤﺩ ﺍﺨﺘﺒﺎﺭ ﻨﺘﻴﺠﺔ ﻋﻠﻰ ﻴﻌﺘﻤﺩ ﺃﻻ
 ﻤﻥ ﻴﻜﻭﻥ ﺃﻥ ﻴﺠﺏ ﺍﻟﺤﺩﻴﺩ ﻋﻨﺼﺭ ﻓﺤﺹ ﻜﺫﻟﻙ. ﺍﻟﺤﺩﻴﺩ ﻋﻨﺼﺭ ﻨﻘﺼﺎﻥ ﺃﺴﺒﺎﺏ ﺒﺠﺎﻨﺏ ﺍﻟﺩﻡ ﻓﻘﺭ
 ﺍﻟﺘﻜﻤﻴﻠﻴﺔ ﺍﻷﻁﻌﻤﺔ ﺘﺩﻋﻴﻡ ﻀﺭﻭﺭﺓ ﺇﻟﻰ ﺒﺎﻹﻀﺎﻓﺔ ﺍﻟﺩﻡ ﻓﻘﺭ ﻟﻤﺭﻀﻰ ﺴﺎﺴﻴﺔﺍﻻ ﺍﻟﻔﺤﻭﺼﺎﺕ ﻀﻤﻥ
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 1
1- INTRODUCTION AND LITERATURE REVIEW 
 
1.1 Definition of iron deficiency: 
Iron deficiency is a state in which the content of iron in the 
body is less than the normal range of the patient’s age and sex.  
Iron deficiency anaemia is also defined as presence of low 
haemoglobin (Hb) concentration, with reduced serum iron and 
abnormal results from tests of serum ferritin, zinc erythrocyte 
protoporphyrin and total iron binding capacity (1,2). 
After release from a relatively hypoxic intra-uterine 
environment, mean haemoglobin concentration falls by (30%) to  
11 g/dl by the eighth postnatal week, followed by a rise to 12.5 g/dl 
at the age of 04 months.  Mean haemoglobin then increases 
gradually to reach 13.5 g/dl in preadolescents.  The lower (95%) 
limit of reference range from 6 months to 4 years for haemoglobin 
is 11 g/dl, with corresponding values of (32%) for packed cell 






1.2 Classification of iron deficiency: 
1.2.1 Iron depletion: is the earliest stage of iron 
deficiency, in which storage of iron is decreased or absent but 
serum iron concentration and blood haemoglobin levels are 
normal(1,4). 
1.2.2 Iron deficiency without anaemia:  is somewhat more 
advanced stage of iron deficiency, characterized by decreased or 
absent storage iron, usually low serum iron concentration and 
transferrin saturation without frank anaemia (1,4). 
1.2.3 Iron deficiency anaemia:  is the most advanced 
stage of iron deficiency.  It is characterized by decreased or absent 
iron storage, low serum iron concentration, low transferrin 
saturation and low haemoglobin concentration or haematocrit 
value (1,4,5). 
1.3 Iron Metabolism: 
   1.3.1 Amount and distribution: 
 The total body iron content of the normal adult varies from 03 
to 05 grams, depending on the sex and weight of the individual.  It 
is greater in males than in females (6,7,8,9).  Iron is distributed in the 
body in several distinct forms: 
1.3.1.1 Haemoglobin iron:  Constitute approximately 
(60%-70%) of the total body iron.  Aged red blood cells (RBCs) are 
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phagocytosed in reticulo-endothelial system (RES).  Nearly all the 
iron derived is reutilized by marrow erythroblasts for haemoglobin 
synthesis. 
1.3.1.2 Storage tissue iron: 
These are available tissue iron in the form of ferritin and 
haemosiderin.  They can be readily mobilized when needed for 
haemoglobin synthesis.  In adults, it is about 1000 – 2000 mg.  Iron 
stores are slowly accumulated during childhood and adolescence.  
It is depleted in iron deficiency anaemia and increased in 
haemosiderosis and haemochromatosis. 
 1.3.1.3       Essential tissue iron: 
These present in the myoglobin of the muscles and in 
certain enzymes of cellular respiration such as cytochromes, 
cytochrome oxidase, catalase and peroxidase.  It is estimated 
about 500 mg in adults. 
 1.3.1.4      Plasma iron: 
It is called transport iron.  About 03 to 04 mg iron present in 
the plasma, where it is bound to a specific protein, transferrin.  
Each molecule of transferrin binds one or two atoms of ferric iron.  
It’s function is transport of iron from the site of absorption or 
release from destroyed (RBCs) to site of haemoglobin synthesis or 
iron storage (4,6-8,10,11). 
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  1.3.2 Iron absorption: 
 Iron absorption depends not only on the amount of iron in the 
diet, but also, on the bioavailability of that iron, as well as the body 
needs for iron.  A normal balanced diet provides 15 mg from which 
about 03 mg is taken by the mucosal cells and only about 01 mg 
(5-10%) of the dietary iron is transferred to the portal blood (7,10,12).  
 Iron absorption can be influenced at several different stages: 
1.3.2.1 Dietary factors: 
Most of the dietary iron is non-haem iron derived from 
cereals.  The lesser component is haem iron derived from 
haemoglobin and myoglobin in meats.  Haem iron is more readily 
absorbed than non-haem iron (6,12,13).  Also the iron that present in 
the food in the ferrus form is more favourable to absorption than 
that of the ferric form (6,12). 
Iron in breast-milk is present in low concentration, but 
uniquely well absorbed and utilized.  However, the total amount of 
iron absorbed by breast fed infants is less than that absorbed by 
those receiving an iron supplemented formula and by 09 months, 
there is evidence of iron deficiency in some breast fed infants 




1.3.2.2 Luminal factors: 
Iron is released from protein complexes by acid and 
proteolytic enzymes in the stomach and small intestine.  Iron is 
maximally absorbed from the duodenum and less well from the 
jejunum, probably because the increasingly alkaline environment 
leads to the formation of insoluble ferric hydroxide complexes.  
Low molecular weight substances such as sugars and ascorbic 
acid, form soluble iron and facilitate attachment of iron to the 
mucosa.  In contrast, phosphates and phytates in the diet bind to 
the iron and inhibit its absorption (3,6,7,12,13). 
Alkalies and tea also reduce iron absorption.  Therapeutic 
ferrus iron salts are well absorbed on an empty stomach and 
absorption is reduced if it was given after meals (12). 
 1.3.2.3    Mucosal factors: 
A variety of mechanisms for binding of non-haem iron to the 
mucosa have been described.  Specific, saturable, receptor 
mediated mechanism and passive diffusion at high doses may 
occur (12).  Haem iron binds to a specific mucosal receptors, 
breaking down the porphyrin ring and releasing its iron into intra 




1.3.3   Iron excretion: 
  There is probably no control mechanism of iron excretion. 
The loss of iron from the body depends on the ferritin iron content 
of the cells lost by desquamation, mostly into the intestinal tract 
and from the skin. The total daily loss by these routes is about     
18 µmol (1mg). Losses can be much higher if there is menorrhagia 
and may then cause iron deficiency. During pregnancy the mean 
extra daily loss to the fetus and placenta is about 27µmol (1.5mg). 
          Normal iron loss is so small and the normal iron stores are 
so large that it would take about 3 years for the patient to develop 
iron-deficiency on a completely iron-free diet. Of course, this period 
is much shorter if there is any abnormal blood loss (14). 
1.3.4    Sources of iron: 
 Iron is obtained from meat especially liver and kidney, egg 
yolk, cereals, pulses, vegetables and fruit.  Red meat contains     
2-3 mg/100 gm in the form of haem while White meat contains          
0.5-1 mg/100 gm and liver has 07-10 mg/100 gm. Hilba (fenugreek 
seed) has very high content 22 mg/100 gm of dry seed and pulses 
have 2-9 mg/100 gm.  Milk, particularly cow’s milk, has low iron 
content.  Considerable amounts of iron may be added to the food 
by cooking in iron utensils(6,10).  
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1.3.5 Iron balance: 
 Under normal circumstances, iron absorption is slightly 
exceeding iron excretion.  A balanced diet contains 10-20 mg of 
iron, of which (10%) or less is absorbed; so that uptake varies from 
1 to 2 mg per day.  Basal losses range from 0.5 to 1.0 mg per    
day (6).   
 The daily iron requirement for haemoglobin synthesis is      
20–25 mg.  It has been pointed out that the body conserves its iron 
stores by re-utilizing the iron derived from the break down of the 
haemoglobin from aged red blood cells.  In normal individuals, red 
blood cells destruction and formation take place at almost identical 
rates.  Thus, in the absence of bleeding or increased demand, 
sufficient iron for haemoglobin synthesis is provided by the 
breakdown of haemoglobin during the destruction of aged red 
blood cells (6, 12). 
 Males normally are in a state of positive iron balance, i.e. the 
amount of iron liberated by the normal destruction of aged red 
blood cells together with the amount absorbed, very slightly 
exceeds the amount required for haemoglobin synthesis and the 
amount lost by excretion.  However, in females of childbearing 
age, the positive balance is only very slender, because of the 
additional loss by menstruation.  Thus, a moderate increase in the 
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menstrual loss, especially if associated with impaired intake, can 
easily induce negative iron balance (6). 
1.3.6  Iron Imbalance:  
Beside iron deficiency and its causes and presentations 
mentioned above, a patient can present with complications of 
increased iron intake.  These patients present in two forms: 
1.3.6.1    Iron overload: 
The absence of a physiological pathway for the excretion of 
excess iron means that patients with increased iron intake are at 
risk of iron overload.  The patients at risk are: 
• Patients with repeated blood transfusions such as 
congenital and/or acquired refractory anaemias. 
• Those who have excess iron absorption: like 
hereditary haemochromatosis and massive ineffective 
erythropoiesis. 
• Those with excess iron uptake such as sub - Saharan 
dietary iron overload from traditional beer of high iron 
content. 
• And those with excess parenteral iron therapy. 
These patients are at risk of progressive accumulation of 
iron and potentially lethal tissue damage leading to 
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haemochromatosis affecting mainly liver, heart and endocrine 
glands (7, 12). 
The iron accumulates initially in the reticulo-endothelial cells 
of the liver, spleen and bone marrow. There are few harmful 
effects but under certain circumstances the distribution may 
progress so that parenchymal damage occurs. Whatever the 
cause of massive iron overload, there may be parenchymal 
accumulation and tissue damage. There are two variations:  
• Haemosiderosis: is defined as an increase in iron 
stores as haemosiderin and is a histological definition. 
It does not necessarily mean that there is an increase 
in the total body iron.  
•   Haemochromatosis:  describes the clinical disorders 
due to parenchymal iron induced damage (9, 14).  
Treatment is by chelation therapy using subcutaneous or 
intravenous deferoxamine. Although some aspects of treatment 
still controversial for the safety of deferoxamine infusion for more 
than 24 hours, the maximal infusion rate, the total amount to be 
given, the serum iron level at which to treat and the end point of 




1.3.6.2   Iron poisoning: 
Iron poisoning continues to be one of the most common 
intoxications in children.  Preparations available commercially 
present potential hazards.  A toxic potential is related to elemental 
iron, which is high in all preparations. 
A safe lower limit for toxic ingestion has not been clearly 
established.  Ingestion of as low as 30 mg/kg can cause toxicity, 
which is only 5 times the recommended daily dose (15, 16). 
It must be emphasized that, because of the nature of 
medication, it is rarely known how many pills in a bottle or how 
many actually were ingested. 
Toxic manifestations are due to either the direct caustic 
effect on the mucosa or the presence of iron with a high level in the 
circulation. In few hours after ingestion, the patient presents with 
nausea, vomiting, lethargy and bleeding.  Followed by a quiescent 
period of several hours which can be deceptive.  Then the 
systemic symptoms of free iron in the circulation develop including 
coma, circulatory collapse, severe metabolic acidosis, cyanosis 
and fever.  Late effect seen days to weeks after ingestion include 
hepatic necrosis and intestinal obstruction due to scarring (15-18). 
Management is through good supportive and symptomatic 
care. Ipecac-induced emesis can be used to remove the drug from 
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the stomach; however, it may mask the gastrointestinal symptoms 
caused by iron. Oral bicarbonate (02%) and magnesium hydroxide 
(milk of magnesia) react with iron to form less soluble, poorly 
absorbed iron salts, but they are toxic and of questionable benefit. 
Activated charcoal does not adsorb iron and should not be used.  
Deferoxamine is a specific chelator and an antidote for iron 
intoxication. It should be administered as an intravenous infusion, 
and continued till the patient is symptom free (15).  
Iron poisoning is most often accidental in paediatric 
population and intentional in adults. Physicians should instruct 
parents to keep iron formulation out of the reach of children (16). 
1.4 Geographical Distribution of iron deficiency: 
         1.4.1 Iron deficiency in Sudan: 
 A study was conducted by El Tohami EA in 1980 about pica 
and its relation to iron deficiency, showed that in (51.4%) of 
children aged 0-6 years had pica which is related to anaemia.       
A subgroup of 120 children were randomly selected and only 62 
children of those who were selected attended; all of them had iron 
deficiency (19). 
 Whereas Mustafa MI in 1988 evaluated the iron status in 
patients with sickle cell anaemia, revealing that as high as (86%) of 
the studied group had iron deficiency (20). 
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 In 2003, Bafakeer SS studied iron status in patients with low 
red cell indices irrespective of the haemoglobin value and found 
that (81%) of the anaemic patients had low red cell indices, 
(72.5%) of them were anaemic and (37.5%) had iron deficiency (21). 
A/Elgader EA in 2004 studied the assessment of iron status in 
Sudanese pregnant ladies and their newborn babies in 80 cases. 
She found that (10%) of the mothers had low haemoglobin, (60%) 
had low serum ferritin and only (7.5%) had low serum iron. While 
(22.5%) of the babies had low haemoglobin, (10%) had low serum 
ferritin and (05%) had low serum iron. Newborn babies who were 
anaemic all their mothers had normal haemoglobin and (11.1%) of 
them had low serum    iron (22).   
 1.4.2 Iron deficiency anaemia worldwide: 
 Iron deficiency and iron deficiency anaemia are common 
nutritional and haematologic disorders worldwide (1,23). An 
estimated 2.15 billion individuals are anaemic because of iron 
deficiency (24).  It is being more prevalent and severe in young 
children (6 – 24 months) and women of reproductive age (25).  It is 
the most prevalent nutritional problem around the world (23).  
 Although (IDA) is not a major health problem in developed 
countries, a specific groups of the population remain endangered.  
Among these groups are young children and adolescents (26). 
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 In (USA) a study was carried in New York in 1988 through 
1994 among 5398 children between the age 6 and 16 years was 
only (03%) had iron deficiency and (0.3%) had iron deficiency 
anaemia (27).  However, another study at the same period in 24894 
children aged one year and older were evaluated for iron status, 
the results showed (09%) of toddlers aged one to two years and 
(09%-11%) of adolescent girls and women of child bearing age 
were iron deficient; of these, iron deficiency anaemia was found in 
(03%) and (02%-05%) respectively (28). 
 In Mexico, a study carried in children 4-6 years in Oaxaca 
city revealed anaemia in (23.7%) and (IDA) in (11.9%). And 
(13.6%) with low iron reserve (29). Another study also was done in 
Mexico in 1999 in 8111 children aged one to two years, revealed 
that the prevalence of anaemia is (50%) in infants less than 02 
years and varied between (14%) and (22%) in 6 -11 years old, and 
positively associated with nutritional status, socio-economic status, 
duration of lactation together with iron and calcium intake (30). 
 In a study in Brazil, 332 children aged 07 to 15 years were 
enrolled in the study. Anaemia was found in (36.2%) of which 
(20%) were iron deficient (31). Another study carried in Turkey in 
1223 children were surveyed. The rate of anaemia was found to be 
(16.9%) overall with a highest prevalence of (18.3%) in the children 
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(00 – 02 years) and (16.3%) in 14+ age group.  The prevalence of 
iron deficiency was found to be (17.2%) overall, being (48%) in the 
infant group, (19.6%) in the children and (14.7%) in the 14+ age 
group (32). 
 A screening for iron deficiency was also carried in 485 
preschool children in Northern Ireland.  The results showed (17%) 
were iron deficient while (03%) of the total number (18.5% of the 
iron deficiency) had iron deficiency anaemia (33). 
 Around Sydney in Australia, iron status was assessed in 678 
children aged 09 to 62 months.  The results revealed that (10.5%) 
had iron depletion, (02.8%) had iron deficiency and (01.1%) had 
iron deficiency anaemia. The 24 to 36 months age group had the 
highest prevalence (03%) of (IDA). Whereas iron depletion and 
iron deficiency were highest among 09 - 23 months age group (34). 
 In Pennsylvania, a screening of 282 children aged 09 to 30 
months old for anaemia and (IDA) revealed that the prevalence of 
anaemia was (35%), iron deficiency without anaemia was (07%) 
and (08%) had iron deficiency with anaemia (35). 
 While in Arab Gulf countries, the prevalence of iron 
deficiency anaemia among preschool children ranged from (20%) 
to (67%) while that among school children ranged from (12.6%) to 
(50%).  The percentages of pregnant women who suffered from 
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(IDA) ranged from (22.7%) to (54%) of them (36). In Al Ain, United 
Arab Emirates, during 1992 and 1993, 309 children aged 01 to 22 
months and their mothers visiting an immunization facility were 
studied for anaemia and the role of iron deficiency in causing 
anaemia.  Anaemia was detected in (03%) of those aged 1-2 
months, (08%) of those aged 3-5 months, and (25%-39%) of those 
aged more than 06 months.  Those who were anaemic, (53%) 
were iron depleted (37). 
 In Africa and Asia where most of the developing countries 
exist, anaemia and iron deficiency seems to be more striking.  A 
nutritional survey was conducted in Tanzania in 660 households of 
2320 subject age from 6 months to 65 years, showed (55%) of the 
subjects had anaemia and (61%) of the anaemia was associated 
with iron deficiency.  And preschool children were the most 
affected group that (84%) of them were anaemic (32). 
 Another study done in eight countries in Africa and Asia in 
school children, anaemia was found to be more than (40%) in the 
five African countries (38). Whereas in Zanzibari, a study in 3595 
school children showed prevalence of anaemia in (62.3%), of 
which (82.7%) was associated with iron insufficiency (39). 
 In Peshawar, Pakistan, a study involving 275 children 
screened for anaemia.  Ninety percent of the children their  
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haemoglobin was below 11 g/dl, (67%) were iron deficient and 
(63%) had iron deficiency anaemia (40). And in Delhi, India, a study 
was conducted in 406 school children randomly selected and 
evaluated for anaemia and it was found to be (41.8%).  Another 
subset of 95 anaemic children aged 5 to 10.9 years are studied for 
the etiology of nutritional anaemia. Pure or mixed (IDA) was found 
in (68.42%), and pure iron deficiency anaemia occurring in    
(41.05%) of this group (41). 
1.5 Clinical Presentation: 
The onset of iron deficiency anaemia is usually insidious.  
While symptoms are those common to all anaemias, nature and 
severity vary with the degree of anaemia and the age of the  
patient (6). 
The common manifestations of (IDA) are pallor, irritability, 
anorexia and decrease in the normal activity.  Pallor is usually 
evident and mild to moderate degree of periorbital or dependant 
oedema may be present (11).  The patient also may present with 
palpitation and dyspnea on exertion (1,3,11).  Headache, parathesia 
and burning sensation of the tongue are symptoms of iron 
deficiency not related to the degree of anaemia (1). 
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Pica, the eating of storage items such as coal, earth, or 
foods in great excess like tomatoes and green vegetables, is more 
common than generally realized, and may be uncovered only if the 
patient is specifically asked (2). But dysphagia is extremely rare and 
when present should raise the possibility of post cricoid’s web; 
Plummer –Vinson syndrome (2,6,7).   
Iron deficiency may have effects on neurologic and 
intellectual function.  A number of reports suggest that iron 
deficiency anaemia and even iron deficiency without significant 
anaemia, affects attention span, alertness and learning of both 
infants and adolescents (42-45). 
Physical findings include:  pallor, glossitis (smooth, red 
tongue), stomatitis and angular cheilitis (1,42). Tachycardia and 
blowing, apical systolic flow murmur is frequently heard but cardiac 
enlargement is unusual (6,42). Koilonychia, loss of cutaneous 
elasticity and changes of texture of hair may occur in advanced 
and severe cases (1,6,42). Splenomegaly is uncommon unless the 
anaemia is severe and may then reflect other diseases such as 
portal hypertension in which the iron deficiency is also a feature (2). 
Retinal hemorrhage and exudates may be seen in severely 




 Diagnosis of iron deficiency anaemia based on three steps: 
1- Confirmation that anaemia is due to iron deficiency 
based on assessment of iron status, bone marrow 
and erythrocyte protoporphyrin. 
2- Full blood count and indicices. 
3- The  cause of iron deficiency. 
1.6.1 Iron status 
Iron is carried in the plasma bound to protein transferrin.  
This molecule binds two atoms of Fe3+ and delivers iron to the cells 
by interaction with the membrane transferrin receptor (46).  About 
(70%) of the total iron is circulating in erythrocyte haemoglobin, 
and up to (25%) of the body iron is stored in the reticulo-
endothelial system in the liver, spleen and bone marrow (14). 
Serum iron can be measured directly, and generally 
decreases and iron stores are depleted.  However, serum iron may 
not reflect iron stores accurately because it is influenced by several 
factors including iron absorption from meals, infection, 
inflammation and diurnal variations (40,47).  Circulating iron, bound to 
the transferrin, comprises only a very small amount of the total 
body iron (0.01%), and has very high turn over rate of 10-20 times 
per day in normal subjects, these factors contribute to the 
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variability of measurement encountered and limit the diagnostic 
usefulness of an individual serum iron measurement (40,48). 
Laboratory assessment of iron status includes serum 
ferritin, serum iron, total iron binding capacity (TIBC), erythrocyte 
protoporphyrin and bone marrow: 
1.6.1.1      Serum ferritin: 
The small quantity of ferritin in the human serum reflects the 
body iron stores.  Measurement of serum ferritin has been widely 
adopted as a test for iron deficiency and iron over load. 
In most normal adults, serum ferritin concentrations lie 
within the range 15–300 µg/dl.  Concentration of less than 15 µg/dl 
indicates depletion of storage iron.  In children, mean levels of 
storage iron are lower and a threshold of 12 µg/dl has been found 
to be appropriate, for detecting iron deficiency (46,49). 
In patients with acute or chronic diseases, interpretation of 
serum ferritin concentration is less straight forwards and patients 
may have serum ferritin concentration of up to 100 µg/dl despite an 
absence of a stainable iron in the bone marrow (1,6,7,46,49). 
1.6.1.2 Serum iron: 
The measurement of serum iron concentration alone 
provides little useful clinical information because; although 
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methodological variation is low; there is considerable variation from 
hour to hour and day to day in normal individuals. 
In the first month of life, mean concentration of serum iron is 
higher than in adults (22 µmol/L), falls to about 12 µmol/L by the 
age of one year and remains at that level throughout the   
childhood (1,6,7,46).  
1.6.1.3 Transferrin and total iron-binding capacity 
(TIBC): 
In the plasma, iron is bound to transferrin and the total iron-
binding capacity is a measure of this protein.  The additional iron 
binding transferrin is known as the ‘unsaturated iron-binding 
capacity (UIBC).  The sum of iron concentration plus the (UIBC) 
give the (TIBC). 
In health, the serum transferrin is 2-3 g/L, and 1 mg of 
transferrin binds 1.4 µg/L of iron.  The normal serum level of 
(TIBC) is 68 + 12.6 µmol/L. The (TIBC) is raised in iron deficiency 
anaemia and in pregnancy. In pathological iron overload, (TIBC) in 
the serum is reduced (1,7,46,50). Serum transferrin receptors level is a 
sensitive measure of iron deficiency and correlates with 
haemoglobin and other laboratory parameters of iron status. It is of 
great value in distinguishing iron deficiency from anaemia of 
chronic diseases (51).  
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    In iron deficiency, the levels are higher than normal, 
where as in the anaemia of chronic and inflammatory diseases, 
levels are slightly but not significantly higher than normal. They can 
be measured by a sensitive enzyme-linked immunosorbant assay 
(ELIZA) technique (51). 
1.6.1.4 Erythrocyte protoporphyrin: 
Protopophyrin represents the stage in the biosynthetic 
pathway of heme immediately before the incoporation of iron (51). 
Protoporphyrin accumulates in the red blood cells in the free form, 
as there is insufficient iron to combine with it to produce haem.  
Estimation of red cell protoporphyrin has been used to diagnose 
iron deficiency before the development of overt hypochromic 
anaemia (51).  
In iron deficiency, red cell protoporphyrin is increased to 
values ranging from 100-600 µg/dl while the normal range is only 
20-40 µg/dl (6,46,49,52). In both iron deficiency and lead poisoning, the 
free erythrocyte protopophyrin (FEP) level is elevated. It is much 
higher in lead poisoning than in iron deficiency. The (FEP) is 
normal in α & β-thalassemia minor. Its elevation occurs as soon as 
the body stores of iron are depleted, but before microcytic anaemia 
develops and therefore an indication for iron therapy even when 
anaemia and microcytosis have not yet developed (51). 
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1.6.1.5 Bone marrow staining: 
The evaluation of marrow iron stores is a sensitive and 
usually reliable means for the diagnosis of iron deficiency anaemia.  
Decreased or absent haemosiderin is characteristic.  
Haemosiderin appears in the unstained marrow film as golden 
refractile granules, but it is more readily and more reliably 
evaluated after staining by Prussian blue method. Iron granules 
which are normally found in the cytoplasm of (10%) or more of 
erythroblasts become rare but may not be entirely absent. 
Marrow examination is seldom necessary for diagnosis, 
unless there are unusual difficulties in the differentiation of (IDA) 
from other causes of hypochromic anaemia (1,6,50,53). 
1.6.2  Other haematologic changes: 
 The essential features are diminished concentration of 
haemoglobin while anaemia is usually of mild to moderate severity. 
The red blood cell count is reduced together with the mean 
corpuscular volume (MCV) and the mean corpuscular haemoglobin 
(MCH). The degree of reduction depends on the severity of the 




 In the blood film, the red blood cells are hypochromic and 
there are microcytosis, anisocytosis and poikilocytosis.  In infants 
and children, hypochromia may occur earlier in the course of iron 
deficiency.  Target cells may sometimes be present (1,6,54,55). 
Reticulocyte count is usually normal, but in severe iron 
deficiency anaemia associated with bleeding, reticulocyte count of 
(03-04%) may occur (51).  
 The white cells count and differential are usually normal 
while the platelets count is usually normal, but it may vary from 
thrombocytopenia to thrombocytosis. Thrombocytopenia is more 
common in severe iron deficiency anaemia while thrombocytosis is 
present when there is an associated bleeding from the gut.  (51,54,55). 
1.6.3     Causes of iron deficiency: 
 Iron deficiency anaemia develops when the supply of iron is 
insufficient for the requirement of the haemoglobin synthesis.  
There are three major factors for the causes of iron deficiency 
anaemia: 
a- Increased physiological demand for iron:  This occurs 
in children during period of growth and women during 
reproductive period. 
b- Pathological blood loss:  Loss of blood to any extent 
causes lowering of the total body iron, especially if it is 
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massive or chronic that can’t be restored by diet such 
as hookworms infestation, bilharsiasis and recurrent 
bleeding from any site. 
c- Inadequate intake:  Occurs in either nutritional 
deficiencies or impaired absorption (1,6,7,12,56-61). 
1.7   Management: 
 Once it has been established that a patient is deficient in 
iron, replacement in therapy should be instituted. Iron may be 
administered in one of several forms; orally; as simple iron form or 
parenterally; as an iron-carbohydrate complex or as a blood 
transfusion. Within 72-96 hours after administration of iron to an 
anaemic child, peripheral reticulocytosis is noted with a peak 
occurring after 1-2 weeks (1,7,14). 
           Reticulocytosis is followed by arise in the haemoglobin level 
which may increase daily by 0.1-0.2 g/dl, and should attain a 
normal value within 02-04 months. Iron medication should be 
continued for 12 weeks after blood values are normal. Body iron is 
restored in 03 to 06 months. 
           Failure of iron therapy occurs when a child does not receive 
the prescribed medication, when iron is given in a form that is 
poorly absorbed or when there is continuing unrecognized blood 
loss such as intestinal or pulmonary loss or in the menstruation. An 
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incorrect original diagnosis of nutritional iron deficiency may be 
revealed by therapeutic failure of iron medication (14).  
1.7.1 Oral iron therapy: 
The patient is encouraged to eat a diet containing all 
nutritional requirements although neither meat nor any other 
dietary article contains enough iron to be useful therapeutically.  
Iron preparations in forms of sulphate, fumarate, gluconate and 
succinate are available in tablets and paediatric mixtures.  The 
daily dose is 150-200 mg/day in adults and 06 mg/kg/day in 
paediatrics as elemental iron to be given divided doses.  
Absorption is best in an empty stomach but side effects are less if 
it was taken after meals. Mild side effects are anticipated such as 
metallic taste, constipation or loose stool (1,7,12,25,62). 
1.7.2   Parenteral iron therapy: 
Occasionally it becomes necessary to administer iron by 
parenteral route as in malabsorption, intolerance to oral iron, iron 
needed in excess to that taken orally or where follow-up is likely to 
be inadequate.  Iron preparations are available in forms of iron 
sorbitol (Jectofer) and iron dextran (Imferon).  Anaphylaxis, 
flushing, nausea, fever, pain and staining at injection sites are 
possible side effects.  Response to treatment is the same as the 
oral medication (1,7,12,25,62,63).  
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1.7.3   Blood transfusion: 
Blood transfusion is preserved to the patients who are 
severely anaemic or those who have signs of heart failure (1,7,12). 
Anaemia that develops slowly, the decision to transfuse these 
patients with (RBCs) should not be based solely on blood 
haemoglobin levels because children with chronic anaemias may 
be asymptomatic despite very low haemoglobin levels.  
The (RBCs) product of choice for children and adolescents 
is the standard suspension of (RBCs) isolated from whole blood by 
centrifugation and stored in an anticoagulant/preservative medium 
at a haematocrit value of about (60%). The usual dose is 10-15 











2 . JUSTIFICATIONS AND OBJECTIVES  
 
2.1. Justifications:  
1.  Iron deficiency anaemia is the commonest cause of 
anaemia worldwide. 
2.  Sudan is one of the developing countries where iron 
deficiency is one of the major nutritional problems. 














2.2. Objectives:  
1.  To determine the prevalence of iron deficiency in ill 
anaemic patients between     6 months & 16 years. 
2.  To study the associated symptoms and signs in 
patients with iron deficiency anaemia. 



















3- PATIENTS AND METHODS 
3.1. Nature of the study:    
 This is a descriptive, cross-sectional, hospital-based, case 
study.  
3.2. Study area: 
The study was conducted at Khartoum Children Emergency 
Hospital (KCEH). 
3.3. Duration of the study: 
  The duration of the study was 08 months started from July-
2004 and ended at February- 2005.  
3.4. Study population: 
   Children presenting with low haemoglobin to Khartoum 
Children Emergency Hospital. 
3.5. Sample size: 
    Sample size was determined according to the following 
formula and was found to be 89 patients. 
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N    =          z2 pq         (64). 
                     d2 
N: Sample size   = 89 patients 
Z   : Statistical certainty = 1.96 at a 95% confidence interval 
P   : probability of success    
Q   : probability of failure (1-p)   
D   : designed margin of error 
3.6. Inclusion criteria: 
       All admitted children between the age of 6 months and 
16 years, with haemoglobin less than 11 grams /dl were enrolled 
in the study. 
3.7. Exclusion criteria: 
Children with age less than 6 months or more than 16 
years were excluded together with those who refused to be 
enrolled in the study. Known patients with haemolytic disorders 
and patients who are already on haematonics for more than        
03 weeks were also excluded.                       
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3.8. Research team: 
Those who contributed in this study were the 
author, paediatric registrars and doctors in the casualty, 
 laboratory technicians, biochemists and a statistician. 
3.9. Methods 
3.9.1. Questionnaire 
      A well prepared questionnaire sheet was designed 
including the personal data, along with the nutritional, socio-
demographic characteristics, family history, medical history and      
a detailed review of symptoms of anaemia. 
   Anthropometric measures along with the clinical signs of 
anaemia and other associated findings were also included.       
2.9.2. Selection of patients: 
  Three days of the week were randomly selected; every 
other day, on Sundays, Tuesdays, and Thursdays, excluding 
Fridays.  
  All admitted children in different wards were investigated for 
haemoglobin by calorimetric method, using finger prick sample. 
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Children satisfying the inclusion criteria with haemoglobin less than 
11 grams/ dl were selected for the study. The personal data along 
with the relevant past and nutritional history beside the clinical 
examination including anthropometric measurement were 
performed and registered in a questionnaire by the author.  
2.9.3. Investigations:       
   Five mls of venous blood were drawn from the patient   and 
collected in 2 separate containers. Two mls in the first container 
which contains anticoagulant, ethylene diamine tetra acetic acid 
(EDTA) for the measurement of red blood cell (RBC) indices 
including haemoglobin (Hb) and (ESR). The remaining 3 mls were 
collected in a plain  container, left to clot and centrifuged to obtain 
2 mls of serum, which was stored at low temperature (less than 
15º C) and used for iron studies namely serum ferritin, serum iron 
and total iron binding capacity (13). 
 2.9.3.1 Haematological tests 
   Haemoglobin and red blood cell (RBC) indices namely 
packed cell volume (PCV), mean corpuscular volume (MCV), mean 
corpuscular haemoglobin (MCH) and mean corpuscular 
haemoglobin concentration (MCHC) were measured by automatic 
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blood counter (Sysmex-Kx-21). Erythrocyte sedimentation rate 
(ESR) was measured by pipetting 01ml of blood in an (ESR) tube 
and sedimentation was read after one hour. 
2.9.3.2. Iron studies: 
•   Serum iron: 
   It was done by a photometric calorimetric test with lipid 
clearing factor. The method uses its own specific kit from “Human” 
to detect the “end point”. Iron reacts with chromazurol B (CAB) and 
cetyl-trimethyl-ammonium-bromide (CTMA). It forms a coloured 
ternary complex with an absorbance maximum at 623 nm. The 
intensity of the colour produced is directly proportional to the 
concentration of iron in the sample. Quality control was insured by 
proper calibration and use of a control sera from the same source 
Humatrol quality control serum (13).  
• Total iron binding capacity (TIBC):   
  Also total iron binding capacity (TIBC) was done by 
photometric calorimetric test. The iron binding protein transferrin in 
serum is saturated upon treatment with an excess of Fe+3 irons. 
Unbound (excess) iron is adsorbed onto aluminum oxide and 
precipitated. The transferrin-bound iron in the supernatant is then 
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determined. The total iron binding capacity is calculated by 
multiplying the result of the iron determination in the supernatant 
by the diluent's factor (13). 
• Serum ferritin:  
Ferritin was measured by sensitive radio-immunoassay (RIA) 
technique. The specific binding site is provided by immunization of 
sheep with human ferritin hormone.  
 Sufficient (polystyrene) test tubes were labeled in duplicates 
and arranged as racks, and then 25 µl were pipetted into each 
tube of the standards (STD), quality control  (QC) sample and the 
patient's sample. And 250 µl of anti-ferritin anti body were added to 
each tube. To the standard, quality control and patients’ samples 
250 µl of tracer were also added.   
 After mixing well and incubated at 37º C for 45 minutes, the 
racks were placed in a magnetic base for 10 minutes, to separate 
the bound fraction from the free fractions by decant and 
supernatant. Lastly, each tube was counted in the gamma counter 
to evaluate the gamma emission per minute, and binding percent 
was plotted versus the concentration, to get standard calibration 
curve. From the curve obtained, the concentration of ferritin in 
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patients' samples were evaluated. This method is bioassay method 
(radio-immunoassay), using radioactive isotope of iodine (I125) 
which is gamma emitter.  
2.9.4. Case definition: 
 A patient is defined as either iron sufficient, having iron 
deficiency without anaemia or having iron deficiency anaemia: 
3.9.4.1. Iron sufficient: 
  The patient is labeled as iron sufficient if his Hb is more 
than 11gm/dl, serum ferritin is more than or equal to 30µg/dl, 
serum iron is more than or equal to 60 µg/dl and iron saturation is 
more than (12%). 
3.9.4.2. Iron deficiency without anaemia: 
The patient is considered as iron deficient without anaemia if 
his Hb is more than 11gm/dl, serum ferritin is less than 30µg/dl, 
serum iron is less than 60 µg/dl and iron saturation is less         
than (12%). 
3.9.4.3. Iron deficiency anaemia:  
The patient is defined as having iron deficiency anaemia if 
his Hb is  less than 11gm/dl, serum ferritin is less than 30µg/dl, 
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serum iron is less than 60 µg/dl and iron saturation is less         
than (12%). 
3.10. Statistical analysis: 
The data were analyzed using Statistical Package for Social 
Sciences (SPSS) computerized program. Chi square test was 
used to compare the associations between the variables . 
3.11. Ethical considerations: 
• Written consent was obtained from the director of the hospital. 
• Informed consent was taken from doctors of the units working 
at the casualty. 
• Informed consent was also taken from the parents. 
• results of the complete blood count (CBC) and iron study 
results of patients who had low iron  levels were handled to 
the patient. 
3.12. Difficulties encountered: 
The main problems faced were: 
• Samples of the (CBC) and iron study were investigated in 
two different laboratories which made difficulties in 
delivering the samples to the 2 laboratories. 
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• Amount of blood which was needed (05mls) was so much 
that led some of the patients to refuse taking the sample, 
although they were fulfilling the inclusion criteria. 
• The study was very costly concerning syringes, containers, 















4 . RESULTS  
 
4.1. Socio-demographic characteristics:  
The total number of the study population was 100 patients, 
of whom 52 (52%) were males and 48 (48%) were females, which 
gave a balanced sample as shown in (Fig. 1).  
The ages of the study population ranged between 06 
months and 16 years. Those below 02 years of age were 36 
patients (36%), between 02-<06 years were 29 patients (29%), 
between 06-10 years were 21 patients (21%) and only 14 patients 
(14%) were above 10 years, this is shown in (Fig. 2).  
Most of the patients reside in Khartoum, but those who 
were originally from the Western Sudan predominated 48 (48%), 
while those from the Northern regions were 18 (18%), from Central 
Sudan were 15 (15%), from the South were 11 (11%) and only 08 




































































4.2.1. Family and social history:  
Regarding age of the mothers in the study group; 05 of 
them (05%) were below 20 years, 57 (57%) were between 20-35 
years and 38 (38%) were above 35 years as shown in (Fig. 4).  
Educational level  of mothers was also obtained. The 
majority 67(67%) were illiterate, 25 (25%) had primary education; 
and only 08 (08%) had secondary education, none had university 
or postgraduate education as shown in (Fig.5). 
Regarding fathers' education, 38 of the fathers (38%) were 
illiterate, 44 (44%) had primary education, 16 (16%) had secondary 
school education and only two (02%) were graduated from the 
university. None had postgraduate education as shown in 
(Table1).  
Concerning fathers' occupation, 14 of them (14%) were 
government employees, 07 (07%) were small scale businessmen, 
18 (18%) were skilled labourers, 16 (16%) were unskilled labourers 
and 45 (45%) were unemployed (Fig. 6).  
Regarding the siblings of the study group, 40 of them 
(40%)  had 3 or less siblings, 43 (43%) had 4-7 siblings and only 


















































Table (1): Educational level of fathers 
  
Educational level No % 
Illiterate  38 39% 
Primary  44 44% 
Secondary  16 16% 
University  02 02% 
Post graduate  00 0.0% 

























































About the family income, 40 patients in the study group 
(40%) were from very low income families, 53 (53%) had low 
income and only 07 (07%) had average income, none had 
satisfactory income (Fig. 8). As for the housing conditions of the 
study group, 31 (31%) had very poor housing conditions, 57 (57%) 
had poor housing conditions and only 12 (12%) had satisfactory 
housing conditions as shown in (Fig. 9).     
4.2.2. Past history:  
From the study findings, it was noticed that most of the 
studied population 98 (98%) were born at term, and only two (02%) 
were born preterm (Fig. 10). Ninety-four patients (94%) were 
singleton whereas 06 (06%) were twin deliveries (Fig. 11). The 
majority of the children 78 (78%) were born with average birth 
weight, 21 (21%) with low birth weight and only one (01%) was 
born with large birth weight as shown in (Fig. 12).  
Only 05 of the studied group (05%) were transfused and 
11 (11%) had started haematonics recently. Thirty-one patients 
(31%) had history of pica, four patients (04%) had positive history 
of bilharsiasis and four patients (04%) had history of worms 
infestation. Those who had recurrent epistaxis were 06 (06%) and 






















































































































Table (2): Some presenting symptoms of the study group    
  
Symptoms and signs 
No. 
% 
Blood transfusion 05  05% 
H. of haematonics 11  11% 
H. of pica  31  31% 
H. of bilharsiasis  04  04% 
H. of worms  04  04% 
Rec. epistaxis  06  06% 









Regarding vaccination, 66 patients (66%) were vaccinated 
up to date, 27 (27%) were partially vaccinated and only seven 
(07%) were not vaccinated (Fig. 13).   
4.2.3. Nutritional history: 
Regarding supplementary feeding of the study group, 36 
patients (36%) had started supplementary feeding before the 4th 
month of age, while 64 (64%) after the 4th month (Fig. 14). Types 
of supplementary feeds that had been received, 65 patients (65%) 
had received cow's milk, 17 (17%) goat's milk, six (06%) formula 
milk and 15 (15%) were on breast milk with other types of food as 
shown in (Table 3).  
Thirteen patients (13%) had not yet been weaned, three 
(03%) were weaned before one year of age, 75 (75%) were 
weaned between 1-2 years while nine (09%) were weaned after 2 
years of age as shown in (Fig. 15). 

















































Table (3): Types of supplementary feeding in the study group 
 
Type d-food No % 
Cow’s milk 65 65% 
Goat’s milk  17 17% 
Formula milk  06 06% 
Breast milk only   12 12% 































4.3. Clinical characteristics:  
4.3.1. Anthropometric characteristics:  
The weight of children in the study group ranged between 
03 kg and 45 kg. The majority 59 (59%) had their weight below the 
3rd centile, 10 (10%) between the 3rd and 10th centile and 31 (31%) 
were above the 10th centile  (Fig. 16). Whereas the height of the 
children in the study group ranged between 56 cm and 180 cm, 32 
patients (32%) heights were below the 3rd centile, 17 (17%) were 
between the 3rd and the 10th centile while the majority 51 (51%) 
were above the 10th centile as shown in (Fig. 17).  
4.3.2. Clinical signs:  
Concerning the clinical signs, most of the patients had 
obvious pallor, 78 patients (78%) were pale, 07 (07%) were very 
pale and 15 (15%) were clinically not pale  (Fig. 18).  
Regarding the other clinical signs, 36 (36%) look wasted, 
26 (26%) had angular stomatitis, 50 (50%) had smooth tongue and 
15 (15%) had oral thrush. No patient in the study group had signs 
of vitamin A deficiency. Five children (05%) were jaundiced, 24 
(24%) had splenomegaly, 17 (17%) presented with abnormal 
respiratory system findings while 10 (10%) had abnormal (CVS) 
and only one patient (01%) had abnormal neurological signs as 




































































Table (4): Some clinical signs in the study group 
  
 64
Signs No % 
Wasting  36 36% 
Angular stomatitis  26 26% 
Smooth tongue 50 50% 
Oral thrush  15 15% 
Jaundice  05 05% 
Splenomegaly  24 24% 
Resp. system  17 17% 
CVS 10 10% 
CNS 01 01% 






oedema, of whom 14 (73.7%) had lower limb oedema, three 
(15.8%) had puffiness of the face and only two patients (10.5%) 
had generalized oedema (Fig. 19).       
4.4. Results of the investigations:  
4.4.1. Haematological results:  
All patients, when tested initially had haemoglobin levels   
below 11 g/dl. When tested by automatic blood counter there were 
only two patients (02%) who were not anaemic as shown in      
(Fig. 20).  
Regarding the relationship between haemoglobin level and 
gender, Hb level was equally distributed between males and 
females. Twenty-seven patients had haemoglobin levels below      
7 g/dl, of those 15 (55.6%) were females and 12 (44.4%) were 
males.  Among the 71 patients (71%) whose Hb was between 7-11 
g/dl, 39 (54.9%) were males and 32 (45.1%) were females. The 
only two males and 32 (45.1%) were females. The only two 
patients who had normal Hb, one was a male and the other was a 
female as shown in (Table 5). Concerning history of worms 
infestation, the four patients (04%) who had worms, 03 of them 
(75%) their Hb level was between 7-11 g/dl and only one patient 
(25%) had normal Hb level, whereas all the four patients with 

















































Table (5): Relationship between haemoglobin  level and the 






< 7 gm/dl  12 (44.4%) 15 (55.6%) 27 (27%) 
7 – 11 gm/dl  39 (54.9%) 32 (45.1%) 71 (71%) 
> 11 gm/dl 01 (50%) 01 (50%) 02 (02%) 
Total  52 48 100 
                      











Table (6): Relationship between haemoglobin level and  
history of worms. 
 
History of worms Haemoglobin 
level 
Worms Bilharzia None 
Total 
< 7 gm/dl  00 (0.0%) 00 (0.0%) 27(27%) 27 (27%)  
7 – 11 gm/dl  03 (75.0%) 04 (100%) 64(64%) 71 (71%) 
> 11 gm/dl 01 (25.0%) 00 (0.0%) 01(01%) 02 (02%) 
Total 04 (04%) 04 (04%) 92 (92%) 100 (100%) 
 









Patients who had splenomegally were 24, 11 of them 
(45.8%) had Hb less than 7 g/dl, 12 (50%) had Hb between 7-11 
g/dl and only one child (4.2%) had normal Hb level (Table 7). 
Concerning patients with history of pica, 31 children were found to 
have such a history. Ten patients (32.3%) had Hb less than 07g/dl, 
21 patients (67.7%) had Hb between 07-11 g/dl and no patient had 
Hb more than 11g/dl as shown in (Table 8).  
When considering the clinical sign of pallor, patients with 
Hb less than 7 g/dl, 19 patients (70.4%) were pale, 07 (25.9%) 
were very pale while only one patient (3.7%) was not pale. Patients 
whose Hb level was between 7 - 11 g/dl, 59 of them (83.1%) were 
pale and 12 (16.9%) were not pale. And the only two patients who 
were not anaemic had no pallor (Table 9). 
Regarding (MCV) values in the studied group, nearly half 
of  the patients (44%) had low levels, and 55 (55%) had normal 
values while only one (01%) had high value of (MCV). Twenty-
seven patients (27%) had (MCH) below the normal range, 66 
(66%) had (MCH) within the normal range while only seven 
patients (07%) had a level above the normal range. Similarly, 26  
patients (26%) had a level of (MCHC) below the normal range, 72 










Yes  No  
Total 
< 7 gm/dl  11  (40.7%) 16  (59.3%) 27 (27%) 
7 – 11 gm/dl  12  (16.9%) 59  (83.1%) 71 (71%) 
> 11 gm/dl 01  (50%) 01  (50%) 02 (02%) 
Total      24  (24%)    76  (76%) 100 (100%) 
 











Table (8): Relationship between the haemoglobin level and 
history of Pica in 31 children 
 
History of Pica Haemoglobin  
level 
Yes  No 
Total 
< 7 gm/dl  10  (37%) 17  (63%) 27 (27%) 
7 – 11 gm/dl  21 (29.6%) 50 (70.4%) 71 (71%) 
> 11 gm/dl 00 (0.0%) 02 (100%) 02 (02%) 
Total 31 (31%) 69 (69%) 100 (100%) 
 










Table (9): Correlation between haemoglobin and pallor in     
the study group 
  
Pallor  Hemoglobin  
level 
Not pale Pale  Very pale 
Total 
< 7 gm/dl  01 (3.7%) 19 (70.4%) 07 (25.9%) 27 (27%) 
7–11 gm/dl  12 (16.9%) 59 (83.1%) 00 (0.0%) 71 (71%) 
> 11 gm/dl 02 (100%) 00  (0.0%) 00 (0.0%) 02  (02%) 
Total  15 (15%)  78   (78%) 07  (07%) 100 (100%) 
 










values. About (PCV), the majority of the patients 65 (65%) had 
normal values, 24 (24%) had low values while only 11 patients 
(11%) had high values as shown in (Table 10).  
Thirty-three patients (33%) had normal (ESR), 54 (54%) 
had high (ESR) while 13 patients (13%) had very high value (>100 
mm/hr) as shown in (Fig. 21).     
4.4.2. Iron study results:  
About serum iron results, two third of the patients (66%) 
had low serum iron, one third (33%) had normal iron level while 
only one (01%) had high serum iron level. Half of the patients 
(50%) had normal ferritin level, 21 (21%) had low level and 29 
(29%) had high serum ferritin level. Concerning the (TIBC), two 
third (65%) had normal level, one third (35%) had high level  and 
none had low level of (TIBC) as shown in (Table 11).  
Concerning the relationship between these iron study 
results, 18 patients (18%) had low level of both serum iron and 
serum ferritin while 13 of these patients (72.2%) had high level of 
(TIBC). Nineteen patients (19%) had both normal serum iron and 
ferritin, of whom 16 (84.2%) had normal (TIBC) while the only one 
who had high serum iron, had high serum ferritin and normal 




Table (10): The red blood cell indices in the study group 
  
 PCV MCV MCH MCHC 
Low 24 (24%) 44 (44%) 27 (27%) 26 (26%) 
Normal 65(65%) 55 (55%) 66(66%) 72 (72%) 
High 11(11%) 01 (01%) 07(07%) 02 (02%) 






































Table (11): Results of iron studies in the study group 
  
  
 Serum iron Serum ferritin TIBC 
Low 
66 (66%) 21 (21%) 00 (0.0%) 
Normal 33 (33%) 50 (50%) 65(65%) 
High 01 (01%) 29 (29%) 35(35%) 















Table (12):  Relationship between serum iron, serum ferritin 
and (TIBC). 
  
TIBC Serum iron Serum ferritin 
Normal High 
Total 
Low 05 13 18 
Normal  19 12 31 
 
Low  
High  12 05 17 
Low  02 01 03 
Normal  16 03 19 
 
Normal  
High  10 01 11 
Low 00 00 00 
Normal 00 00 00 
 
High  
High   01 00 01 
Total   65 35 100 
 
                 Low S. iron X2 = 7.54                       P < 0.02  




Regarding the correlation between (MCH) and serum iron, 
27 patients (27%) who had low (MCH), 26 of them (96.3%) had low 
serum iron and only one (3.7%) had normal iron. Patients who had 
normal (MCH), 38 patients (57.6%) had low serum iron, 28 patients 
(42.4%) had normal iron level and the only one who had high iron 
level also had high (MCH) as shown in (Table 13).  
Regarding the relationship between (MCH) and serum 
ferritin, Among the 27 patients who had low (MCH), 08 patients 
(29.6%) had low serum ferritin, 13 (48.1%) had normal ferritin and 
06 (22.2%) had high ferritin level. Patients who had normal (MCH) 
were 66, 13 of them (19.7%) had low ferritin level, 31 (47%) had 
normal ferritin and 22 (33.3%) had high ferritin level. The seven 
patients who had high (MCH), 06 patients (85.7%) had normal 
ferritin while only one patient (14.3%) had high serum ferritin level 
as shown in (Table 14).  
About the relationship between (MCV) and serum iron, 
Among the 44 patients who had low (MCV), 43 of them (97.7%) 
had low serum iron and only one (2.3%) had normal iron level. 
Fifty-five patients had normal (MCV), 23 of them (41.8%) had low 
serum iron and 32 (58.2%) had normal iron level. The only one 




Table (13): Relationship between ( MCH) and serum iron in the 
study group 
 
Serum iron  MCH 
Low  Normal  High  
Total 
Low  26 (96.3%) 01 (3.7%) 00 (0.0%) 27 (27%) 
Normal  38 (57.6%) 28 (42.4%) 00 (0.0%) 66 (66%) 
High  02 (28.6%) 04 (57.1%) 01 (14.3%) 07 (07%) 
Total  66 (66%) 33 (33%)  01 (01%)  100 (100%) 
 












Table (14): Relationship between (MCH) and ferritin level in 
the study group 
 
 
Serum ferritin  MCH 
Low  Normal  High  
Total 
Low  08 (29.6%) 13 (48.1%) 06 (22.2%) 27 (27%) 
Normal  13 (19.7%) 31(47.0%) 22 (33.3%) 66 (66%) 
High  00 (0.0%) 06 (85.7%) 01(14.3%) 07 (07%) 
Total  21 (21%)  50 (50%)  29 (29%)  100 (100%) 
 

















Serum iron level   
MCV 
Low  Normal  High  
Total 
Low  43 (97.7%) 01(2.3%) 00 (0.0%) 44 (44%) 
Normal  23 (41.8%) 32 (58.2%) 00  (0.0%) 55 (55%) 
High  00  (0.0%) 00 (0.0%) 01(100%) 01 (01%) 
Total  66 (66%)  33 (33%)  01 (01%) 100 (100%) 
 











Regarding the correlation between the (MCV) and ferritin 
level, 44 patients (44%) had low (MCV), of whom 15 (34.1%) had 
low ferritin, 18 (40.9%) had normal ferritin and 11 (25%) had high 
ferritin level. As for the patients with normal (MCV), 06 patients 
(10.9%) had low ferritin, 32 (58.2%) had normal ferritin and 17 
(30.9%) had high ferritin level. The only patient who had high 
(MCV) also had high ferritin level (Table 16).    
When we looked into the serum iron status in the four 
patients who had history of worms infestation, 03 of them (75%) 
were found to have low serum iron while one (25%) had normal 
iron. However, in bilharsiasis the reverse is true, three out of the 
four patients with bilharsiasis (75%) had normal serum iron and 
only one had low iron level (Table 17).  
All mothers whose ages were below 20 years, their 
children had low serum iron, while those with ages between 20-35 
years, 39 of them (68.4%) their children had low serum iron and 18 
(39.5%) their children had normal iron level. Mothers whose age 
was above 35 years, 22 (57.9%) of their children had low serum 
iron, 15 (39.5%) had normal iron and only one (2.6%) had high iron 









Serum ferritin level   
MCV 
Low  Normal  High  
Total 
Low  15 (34.1%) 18 (40.9%) 11 (25%) 44 (44%) 
Normal  06 (10.9%) 32 (58.2%) 17 (30.9%) 55 (55%) 
High  00 (0.0%) 00 (0.0%) 01 (100%) 01 (01%) 
Total  21 (21%)  50 (50%)  29 (29%)  100 (100%) 
 













Table (17): Relationship between serum iron level and 
history of worms. 
 
 
History of worms  
Serum iron 
Worms Bilharsiasis None  
Total 
Low  03 (4.5%) 01 (1.5%) 62 (93.9%) 66 (66%) 
Normal  01 (3.0%) 03 (9.1%) 29 (87.9%) 33 (33%) 
High  00 (0.0%) 00  (0.0%) 01 (100%) 01 (01%) 
Total  04 (04%)  04 (04%)  92 (92%)  100 (100%) 
 












Table (18): Relationship between mothers’ age and serum iron 
level  in the study group. 
 
Serum iron level Mother age 
in years Low  Normal  High  
Total 
< 20 yrs 05 (100%) 00 (0.0%) 00 (0.0%) 05 (05%) 
20 – 35 yrs 39 (68.4%) 18 (31.6%) 00 (0.0%) 57 (57%) 
> 35 yrs 22 (57.9%) 15 (39.5%) 01 (2.6%) 38 (38%) 
Total 66 (66%)  33 (33%)  01 (01%) 100 (100%) 
 










About the 24 patients who had splenomegaly, 18 patients 
(75%) had low serum iron, 05 (20.8%) had normal serum iron while 
only one patient (4.2%) had high iron level as shown in (Table 19).  
Patients who had history of pica were 31, of whom 27 (87.1%) had 
low serum iron and only four (12.9%) had normal iron level. None 
had high serum iron level (Table 20).  
Regarding ferritin level, 07 patients (22.6%) had low 
ferritin, 14 (45.2%) had normal ferritin and 10 patients (32.3%) had 
high ferritin level (Table 21). In co-relating serum iron with the type 
of supplementary feeds given to those children, it was found that 
patients who were supplemented with cow's milk, 38 of them 
(58.5%) had low serum iron, 27 (41.5%) had normal iron level 
(Table 22). While those who were supplemented with goat's milk, 
15 of them (88.2%) had low serum iron and only two (11.8%) had 
normal iron level (Table 23).  
When considering the clinical sign of pallor, patients with 
low serum iron, 53 (80.3%) were pale, 06 (9.1%) were very pale 
and only seven (10.6%) were not pale. Patients with normal serum 
iron, 25 of them (75.8%) were pale and 08 (24.2%) had no pallor, 
while only one patient who had high iron level appeared very pale 




Table (19): Relationship between serum iron level and 
splenomegaly  
 
Splenomegaly Serum iron 
Yes No 
Total 
Low  18  (27.3%) 48 (72.7%) 66 (66%) 
Normal  05  (15.2%) 28 (84.8%) 33 (33%) 
High  01 (100%) 00 (0.0%) 01 (01%) 
Total  24 (24%)  76 (76%)  100 (100%) 
 












Table (20): Relationship between serum iron level and   
history  of pica in the study group 
 
History of pica 
Serum iron 
level  Yes No 
Total 
Low  27 (40.9%) 39  (59.1%) 66 (66%) 
Normal  04  (12.1%) 29  (87.9%) 33 (33%) 
High  00  (0.0%) 01  (100%) 01 (01%) 
Total  31 (31%)  69 (69%)  100 (100%) 
 











Table (21): Correlation between serum ferritin and history      
of pica in the study group 
 
Serum ferritin level  History of 
pica Low  Normal  High  
Total 
Yes 07 (22.6%) 14 (45.2%) 10 (32.3%) 31 (31%) 
No 14 (20.3%) 36 (52.2%) 19 (27.5%) 69  (69%) 
Total 21 (21%)  50 (50%)  29 (29%)  100 (100%)
 













Table (22): Relationship between supplements with cow’s milk 
and serum iron level 
 
Serum Iron  Cow’s milks 
supplements  
Low  Normal  High  
Total 
Yes 38 (58.5%) 27 (41.5%) 00 (0.0%) 65 (65%) 
No  28 (80%) 06 (17.1%) 01 (2.9%) 35 (35%) 
Total  66 (66%)  33 (33%)  01 (01%) 100 (100%) 
 












Table (23): Relationship between serum iron level and 
supplements with goat’s milk 
 
Serum iron level Supplements 
with goat’s milk  
Low  Normal  High  
Total 
Yes 15 (88.2%) 02 (11.8%) 00 (0.0%) 17 (17%) 
No  51 (61.4%) 31 (37.3%) 01(1.2%) 83 (83%) 
Total  66  (66%)  33 (33%)  01 (01%)  100 (100%)
 












Table (24): Correlation between serum iron and the clinical 
signs of pallor in the study group 
 
Pallor  Serum iron 
level 
Not pale Pale  Very pale 
Total 
Low 07(10.6%) 53 (80.3%) 06 (9.1%) 66 (66%) 
Normal 08 (24.2%) 25 (75.8%) 00 (0.0%) 33 (33%) 
High 00 (0.0%) 00 (0.0%) 01(100%) 01 (01%) 
Total  15 (15%)  78 (78%)  07 (07%) 100 (100%) 
  










Regarding smooth tongue, patients with low iron level, 37 
(56.1%) had smooth tongue and 29 (43.9%) had not, while those 
with normal iron level, 13 (39.4%) had smooth tongue and 20 
(60.4%) had no smooth tongue. The only one who had high iron 

























level Yes No 
Total 
Low 37 (56.1%) 29 (43.9%) 66 (66%) 
Normal 13 (39.4%) 20 (60.6%) 33 (33%) 
High 00 (0.0%) 01 (100%) 01 (01%) 
Total  50 (50%)  50 (50%)  100 (100%) 
  










5 . DISCUSSION  
 
5.1. Socio-demographic characteristics:  
The total number of the studied population was 100 
children, 52 of them were males (52%) and 48 were females 
(48%). This finding was different from a study done in India in 
which females predominated (77%), however, it was similar to that 
which was done in (USA) in which females were (53%) of the 
studied group (31,37).   
Age group ranged between 06 months and 16 years with 
peak age below 02 years. Younger infants were not enrolled, to 
avoid the physiological anaemia.  
Majority of patients (59%)  were originally from West or 
South Sudan and lived mainly in the outskirts of Khartoum town. 
This could be explained by the fact that the free resources of the 
hospitals are mainly utilized by the lower social class. Most of 
these people being recent immigrants or displaced by war, drought 





5.2 History:  
5.2.1 Family and social history:  
Only five of the mothers (05%) were below 20 years of age 
and 38 (38%) were above 35 years. This indicate that children of 
elderly mothers are more susceptible to anaemia. This difference 
may be due to the fact that mothers with multiple deliveries are 
more prone to depletion of body iron stores which can be reflected 
in their children. 
Regarding mothers' education, the majority (67%) were 
illiterate, which plays an important role in child's nutritional 
adequacy. As Sudan is a developing country, this percentage of 
high illiteracy is well understood, but to be living in the capital and 
be illiterate is quite  unfair. However, they could have migrated 
recently from rural areas as shown above, the majority were from 
regions of conflicts.  
Fathers' occupation reflects the economical status and the 
social class. Nearly half of the fathers (45%) were unemployed. 
This reflects the instability of the child's nutritional status. This was 
clearly reflected in the family income, which showed that (93%) of 
the patients’ families had low or very low income. Moreover, (88%) 
of the study group had poor or very poor housing condition.  
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5.2.2  Past history:  
From the history of birth, most of these patients were born 
normally, (98%) were term, (94%) were singleton and (78%) with 
average birth weight. This indicates that most of these patients' 
anaemia was acquired later in life and that it was mainly nutritional 
in origin.  
Patients who had a history of pica were (31%). This is 
similar to a study which was done by El Tohami EA in 1980, that 
showed (40.3%) of the patients had history of pica (38). 
Very few patients who had history of worms infestation or 
bilharziasis, accounting for only (04%) each. This is may be due 
the fact that Khartoum State is not an endemic area of bilharziasis 
or other worms. The majority of the studied group (65%) were 
below 05 years of age and consequently they were not expected to 
be exposed to  the sources of bilharzia transmission at this age. So 
worms and bilharziasis  were not major causes of iron deficiency in 
this study group. This is similar to a study carried in Ethiopia in 230 
anaemic patients showed that the incidence of hookworms were 
(0.4%) and contributed little in their anaemia (65). However, it is not 
similar to the findings in other countries such as Zanzibar where 
hookworms accounting for (33.8%), were one of the major causes 
of iron deficiency in children below 05 years of age (66). Another 
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study conducted in Delhi (India) in 406 children and found that 
(47.5%) of the children studied had history of worm infestations (37). 
Moreover, in north-west Australia, the prevalence of hookworms in 
children aged 05-14 years was (93%) with iron deficiency (79%) in 
this age group (70).  
None of the patients had history of dysphagia that may 
suggest Plummer-Vinson syndrome. This is consistent with the 
literature that denoted: “Plummer-Vinson syndrome usually occurs 
in adults, rarely in adolescents, however, there have been no 
previous reports in the English-language literature of the syndrome 
occurring in childhood". The first case that was reported in the year 
2000 was in 6 years old child in United Leeds Teaching Hospital, 
England (71). 
The majority of the patients (66%) were vaccinated up to 
date, (27%) were incompletely vaccinated while only (07%) were 
not vaccinated. This reflects the awareness of the families about 
the importance of vaccination, and also could be explained by the 
efforts of the team of the National Programme of Immunization 
(EPI).  
5.2.3 Nutritional history:  
Regarding supplementary feeding, about two thirds of the 
patients (64%) started supplementary feeding after the fourth 
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month. The majority (65%) were supplemented with cow's milk 
which also, like breast milk, contains small amount of iron while 
only (10%) of its iron content is absorbed (71). This goes with a 
study conducted in Dublin (England) showing that at age 12 
months, cows’ milk consumption was negatively associated with 
iron status (72). 
As mentioned above; most of the families were of low 
social class, the other supplementary feeds could also be deficient 
in iron. All these factors could predispose to the  development of  
anaemia and iron deficiency in those children at earlier stages of 
their lives. 
Concerning weaning, it was found to be adequate for 
(75%) of the patients who were weaned between age 1-2 years, 
with only (03%) who were weaned before one year of age. This 
reflects that breast milk was the main source of feeding in early 
infancy in our study population.  
5.3. Clinical characteristics:  
5.3.1 Anthropometric characteristics: 
The weight of the majority of the patients (59%) was below 
the 3rd centile while almost half of them (51%) had normal height. 
This reflects that their problems were acute affecting weight loss 
together with anaemia without affecting height so much.  
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5.3.2 Clinical signs: 
Regarding the clinical sign of pallor, (85%) of the patients 
looked pale or very pale. This indicates that the clinical sign of 
pallor can give a clue about the amount of haemoglobin in the 
blood and directs the doctor towards investigating the patient for 
anaemia.  
Other clinical signs such as wasting (36%) angular 
stomatitis (26%), oral thrush (15%), jaundice (05%) as well as 
(CVS), respiratory and neurological signs were not related to iron 
deficiency. They could be due to an underlying illness that led to 
anaemia or a concomitant complication of the underlying illness 
such as oral thrush and angular stomatitis. Whereas other signs 
like smooth tongue, which was in (50%) of study group and 
splenomegaly in (24%), were features of chronic iron deficiency. 
As splenomegaly is an uncommon feature in iron deficiency, this 
high percentage (24%) could be due to other underlying problems 
and not due to iron deficiency.  
Nineteen percent of the patients had oedema and it was 
not a presenting feature of iron deficiency. Although it might be due 
to anaemic heart failure, yet it may be due to many other diseases 
which present affecting various parts of the body.  
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5.4 Results of the investigations:  
5.4.1  Haematological results:  
All patients were anaemic by calorimetric method. When 
automatic blood counter was used, (98%) of them were still 
anaemic, indicating the high sensitivity of calorimetric method for 
checking the haemoglobin level.  
Haemoglobin level was equally distributed between males 
and females and there was no significant difference between them 
(P=0.65). Females, during reproductive age, are more prone to 
develop anaemia and iron deficiency than males (21). However, this 
was not observed in  the study group as they  were all below this 
age.  
Anaemic patients who had lower haemoglobin level had a 
higher percentage value of splenomegaly. That (40.7%) their Hb 
below 07 gm/dl with (16.9%) had Hb of 7-11gm/dl, with significant 
association between haemoglobin level and splenomegaly 
(P=0.03). This could be explained by the fact that, the severity of 
the disease leading to a reduced  haemoglobin level, may cause 
more other detectable features which splenomegaly is one of 
them. Moreover, it could be a secondary site for red blood cells 
destruction  (hypersplenism), leading to much lower haemoglobin.  
 103
There was no significant correlation between haemoglobin 
level and history of pica (P=0.49). This is true for anaemia which 
has different etiological factors while pica is related to iron 
deficiency only and not associated with other causes of anaemia. 
However, there was significant correlation between haemoglobin 
level and clinical pallor (P=0.01). This means that clinical pallor 
reflects the haemoglobin level of the patients.  
Most of the results of the red blood cell indicies were either 
low or normal such as (PCV) values (24%) were low and (65%) 
were normal. While (44%) of the (MCV) values were low and 
(55%) were normal. Moreover, (27%) of the (MCH) results were 
low and (66%) were normal. These results reflect the high 
sensitivity of the red blood cell indicies to change by different 
haematological effects and they can be used as a clue for the 
underlying deficiency. In these results, (44%) of the patients had 
low (MCV) which is indicative of microcytic cells and this is related 
to iron deficiency which is one of the causes of microcytosis. This 
goes with a study conducted in Ohio (USA) in 305 children 
revealed that the prevalence of microcytic anaemia was (08%) and 
was associated with iron deficiency (73). However, it was not similar 
to another study carried in Texas (USA) in 321 infants between  
09-12 months showing that haematocrit was not an adequate 
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screening test for iron deficiency (74). This could be explained by 
the fact that haematocrit is related to both red cell count and 
(MCV). Moreover, the study used a younger age group with a 
narrow range that can not be applied for all children. 
Only (13%) of the studied group had normal erythrocyte 
sedimentation rate (ESR). These elevated (ESR) results could be 
either due to the underlying illnesses, as these children were 
admitted to the hospital for medical problems or due to the 
anaemia itself which could raise the (ESR).  
5.4.2  Iron study results:  
Concerning serum iron, the majority of the patients (66%) 
were having low serum iron. This is different from the results of a 
study carried in (USA) which reported iron deficiency in only (15%) 
of the study population, they were (08%) with anaemia and (07%) 
without anaemia (13). However, it is similar to the findings of the 
studies conducted in India showing iron deficiency anaemia in 
(68.42%), and in Tanzania which showed that (61%) of the 
anaemic patients had iron deficiency (37,28). While in Sudan, 
Mustafa MI showed that (86%) of the patients with sickle cell 
anaemia had iron deficiency (39). Moreover, Bafakeer SS in his 
study showed that (63.6%) of the children's group had low serum 
iron (40). From the data mentioned above, having a far higher 
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percentage of iron deficiency in these children than in (USA) is 
expected, as it is a developed country. However, the results were 
similar to the studies from Delhi (India) and Tanzania as they were 
developing countries along with the study carried in Sudan by 
Bafakeer SS. 
About the results of the study of the sicklers conducted by 
Mustfa MI, they were a group of haemolytic anaemia not included 
in my study. It is unlikely that children with sickle cell anaemia to 
have high prevalence of iron deficiency .  
Regarding serum ferritin, half of the patients 50 (50%) had 
normal ferritin, 29 (29%) had high ferritin level and only 21 of study 
group (21%) had low serum ferritin level. Although it was 
measured by a very sensitive radio-immunoassay technique, this 
low percentage of low level could be attributed to the fact that 
serum ferritin is an acute phase reactant protein that can be 
normal or elevated during inflammation (65). Moreover, all patients 
were admitted to hospitals with medical problems, so serum ferritin 
can not be taken alone in ill patients in such a situation for 
evaluation of iron status. 
About the total iron binding capacity (TIBC), all of the 
results were either normal (65%) or high (35%) reflecting the low 
level of serum iron mentioned above. This differs from the study 
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which was conducted by Bafakeer SS that showing the results of 
children's group in whom the majority (45.5%)  were having low 
(TIBC) level (40).  
Regarding the association between serum iron and (MCV), 
the 44 patients who had low serum iron (44%), 43 of them (97.7%) 
had low serum iron and only one (02.3%) had normal iron level. 
While the 55 patients who had normal serum iron (55%), 23 of 
them (41.8%) had low serum iron and 32 (58.2%) had normal iron 
level. The only one who had high (MCV) also had high ferritin level. 
This association statistically is very significant (P < 0.01).  
Considering the relationship between serum ferritin and 
the (MCV), 44 patients (44%) who had low (MCV), 15 of whom 
(34.1%) had low serum ferritin, 18 (40.9%) had normal ferritin and 
11 (25%) had high ferritin level. While the 55 patients who had 
normal (MCV). 06 patients (10.9%) had low serum ferritin, 32 
(58.2%) had normal ferritin and 17 (30.9%) had high ferritin level. 
The only one who had high (MCV) also had high serum ferritin. 
This relationship was also statistically significant (P<0.03), 
indicating that the reduction in serum iron and ferritin has thier 
effect on reducing (MCV) level.  
Concerning the correlation between serum iron and history 
of worms infestation, it was not significant (P=0.48), as well as the 
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relationship between the serum iron and splenomegaly (p<0.08). 
Whereas the association between iron level and history of pica, the 
31 patients who had history of pica, 27 of them (87.1%) had low 
serum iron and only four (12.9) had normal iron level. This 
association is very significant (P < 0.01). However, it was not 
statistically significant when the history of pica was compared with 
ferritin level (P = 0.81).  
More than half of the patients who were supplemented with 
cow's milk (58.5%) had low serum iron while (41.5%) had normal 
serum iron and non had high iron level. This association is 
statistically significant (P<0.02). This is also similar to the 
association between goat's milk and serum iron of the children in 
whom (88.2%) had low serum iron while (11.8%) had normal iron 
level (P < 0.01). From these results, cow's milk and goat's milk 
seem to have a role in developing iron deficiency if given as a 
supplementary feeds without supplying the infant with iron or iron 
rich food.  
Regarding pallor, (80.3) of the Patients who had low serum 
iron, (80.3%) of them appeared pale, (09.1%) very pale and only 
(10.6%) looked normal. This correlation between iron level and 
clinical sign of pallor seems to be significant (P = 0.01). While 
these patients with such level of serum iron, (56.1%) of them had 
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smooth tongue and (43.9%) had not, and this relationship was 




















6- CONCLUSION AND RECOMMENDATIONS 
 
6.1 CONCLUSION  
 
 Iron deficiency is the commonest cause of anaemia, which is 
mainly nutritional. 
 Anaemia and iron deficiency anaemia are more common 
among people of lower social class, who have recently 
migrated to Khartoum State.  
 In iron deficiency, it is difficult to differentiate between 
splenomegaly due to iron deficiency from that due to other 
causes. However, it is a common finding in ill patients, although 
it is  a rare sign in iron deficiency in apparently healthy children.  
 Pica is one of the common presenting symptoms of iron 
deficiency.  
 Child's nutrition, mother's education and father's economical 
status play a major role in iron deficiency anaemia among 
children.  
 Cow's milk and goat's milk have a great effect in reducing 
serum iron if used as supplement food during infancy without 
iron supplementation.  
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 Worms and bilharziasis were not major problems in Khartoum 
State.   
 Serum ferritin is a single sensitive test which reflects iron 
stores. However, during infection it is not useful alone for 
evaluation of iron status.  
 Other red blood cell indices are sensitive to changes due to iron 
deficiency such as packed cell volume (PCV), mean 
corpuscular volume(MCV), mean corpuscular haemoglobin 
(MCH) and mean corpuscular haemoglobin concentration 














6.2  RECOMMENDATIONS  
 
 More studies involving large numbers from different clusters are 
needed.  
 Further studies for evaluation of other causes of anaemia are 
important and will be valuable.  
 Etiological causes of iron deficiency anaemia should be 
included in future studies. 
 Detection of haemolytic anaemia using reticulocyte count must 
be considered in the future researches.  
 Reference values for haemoglobin and iron study parameters 
need to be studied in the future researches and studies.  
 Peripheral blood picture should be included in the future 
studies. 
 Patients who are anaemic, need evaluation of their anaemia 
and should be started on iron supplement if they are iron 
deficient.  
 Iron fortification of supplementary food should be adopted in 
our country.  
 Formula milk should be substituted for cow’s milk and goat’s 
milk  as supplementary food in infants together with iron rich 
foodstuffs such as Hilba (fenugreek seed), cereals and pulses. 
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 Iron studies should be included in the routine investigations of 
the patients with anaemia. 
 Education schools for illiterate women together with health 
education sessions should be established in the outskirts of 
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